Nasdaq

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

WAYNE, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the ...
Business Wire

NICE Gives Go Ahead To NeoTract’s Groundbreaking UroLift® Prostate Implant That Can Preserve Sexual Function While Offering Urinary Symptom Relief for Millions of Men ...

PLEASANTON, Calif.--(BUSINESS WIRE)--NeoTract, Inc., today announced that the UK’s National Institute for Health and Clinical Excellence (NICE) has issued an interventional Procedure Guidance (IPG) ...
Business Insider

NeoTract Designates Dr. Miguel Mercado as UroLift® Center of Excellence

PLEASANTON, Calif., July 9, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
Nasdaq

Teleflex (TFX) Real-World Data Outcome Supports UroLift System

Teleflex Incorporated TFX recently unveiled the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System together with real-world data presentations at the American Urological Association ...
News Medical

AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced that the American Urological Association (AUA) has recommended ...
Business Wire

Teleflex Announces 100,000 Patients Treated for Enlarged Prostate with UroLift ® System

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) today announced that 100,000 patients have been treated globally with its minimally invasive UroLift ® System, a safe and effective ...
Seeking Alpha

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over ...

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American ...
News Medical

NeoTract announces results of study measuring costs and patient outcomes of UroLift System

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the results of an independent analysis measuring costs and ...
National Institute for Health and Care Excellence

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.
The Punch Newspapers

How UroLift surgery offers prostate patients hope, less erectile damage risk

UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
National Institute for Health and Care Excellence

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

The UroLift System (Teleflex Inc.) is used to do a prostatic urethral lift, a procedure that relieves lower urinary tract symptoms. It uses implants to pull excess prostatic tissue away from the ...